Novel transcript, antisense to FXR1 (ENSG00000296188)

This entity is an annotated **novel antisense RNA transcript** identified on the opposite DNA strand relative to the FXR1 (Fragile X mental retardation syndrome–related protein 1) gene locus in human genomic databases. Antisense RNAs can sometimes regulate the expression, stability, or splicing of their cognate sense gene, but for this transcript (ENSG00000296188), there is no experimental evidence of such regulatory function. It is **not a therapeutic target, receptor, enzyme, transporter, or clinically validated molecule**. The entry reflects genome annotation efforts rather than validated biology, and there is **no reported biological function, disease relevance, or drug interactions** associated with it. **Context:** - **FXR1 (the sense gene)** codes for a well-studied RNA-binding protein involved in mRNA stability and translation regulation, stress response, and neuroinflammation[1][2]. - The designation "novel antisense transcript" denotes that the RNA species is transcribed from the opposite strand of the FXR1 gene, but does not mean it encodes similar or related biological function. - Such entries are frequently the result of high-throughput genome annotation and should not be confused for validated protein-coding or functional RNAs. **Note:** There is **no evidence** that ENSG00000296188 is a protein-coding gene, a therapeutic target, or a functionally characterized non-coding RNA. Its existence is primarily supported by transcriptomic data, with **no associated disease, pharmacology, or biomarker relevance**. This class of entity generally requires further research to establish any biological significance.

Other names

Antisense to FXR1FXR1-ASENSG00000296188